ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 56 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2019 | $1,000 | -66.7% | 1,468 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 1,468 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | 0.0% | 1,468 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | -16.7% | 1,468 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | 0.0% | 1,468 | 0.0% | 0.00% | – |
Q4 2017 | $6,000 | -25.0% | 1,468 | -6.4% | 0.00% | – |
Q3 2017 | $8,000 | -95.5% | 1,568 | -95.4% | 0.00% | -100.0% |
Q2 2017 | $179,000 | +2883.3% | 34,433 | +2245.6% | 0.01% | – |
Q1 2017 | $6,000 | +20.0% | 1,468 | 0.0% | 0.00% | – |
Q4 2016 | $5,000 | -37.5% | 1,468 | -40.5% | 0.00% | – |
Q3 2016 | $8,000 | +100.0% | 2,468 | +68.1% | 0.00% | – |
Q2 2016 | $4,000 | – | 1,468 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
Founders Capital Management | 8,000 | $6,000 | 0.01% |
Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
Firestone Capital Management | 5,200 | $4,000 | 0.00% |
MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |